Venus Concept Inc. (NASDAQ:VERO) Sees Significant Growth in Short Interest

Venus Concept Inc. (NASDAQ:VERO) was the recipient of a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 199,499 shares, a growth of 113.1% from the December 15th total of 93,597 shares. Based on an average trading volume of 4,414,860 shares, the short-interest ratio is currently 0.0 days. Currently, 19.5% of the company’s stock are sold short. Currently, 19.5% of the company’s stock are sold short. Based on an average trading volume of 4,414,860 shares, the short-interest ratio is currently 0.0 days.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Venus Concept in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Venus Concept has an average rating of “Sell”.

Venus Concept Stock Up 648.3%

NASDAQ:VERO traded up $9.27 during trading hours on Friday, reaching $10.70. 207,855,013 shares of the company traded hands, compared to its average volume of 17,887,186. The company has a current ratio of 0.90, a quick ratio of 0.59 and a debt-to-equity ratio of 1.59. The business’s 50-day moving average price is $1.77 and its two-hundred day moving average price is $2.18. Venus Concept has a 1 year low of $1.39 and a 1 year high of $14.50. The stock has a market capitalization of $15.19 million, a P/E ratio of -0.22 and a beta of -0.04.

Venus Concept (NASDAQ:VERO) last issued its quarterly earnings results on Thursday, November 13th. The company reported ($12.14) earnings per share for the quarter, missing the consensus estimate of ($3.61) by ($8.53). The company had revenue of $13.78 million for the quarter, compared to the consensus estimate of $14.48 million. Venus Concept had a negative net margin of 92.76% and a negative return on equity of 1,904.25%.

About Venus Concept

Venus Concept Ltd. (NASDAQ: VERO) is a Canada-based medical aesthetic device company that designs, develops and commercializes minimally and noninvasive solutions for face and body rejuvenation. The company’s core product portfolio leverages proprietary technologies such as multi-polar radio frequency, pulsed electromagnetic fields and intense pulsed light to offer treatments for skin tightening, body contouring, wrinkle reduction and vascular lesion removal.

Among its flagship offerings are the Venus Legacy platform, which combines radio frequency and electromagnetic pulses for cellulite reduction and circumferential reduction, and the Venus Versa system, a multi-application device for facial revitalization, acne treatment, hair removal and photorejuvenation.